India: Annual Conference for Physiotherapy Professional, the official launch of Hilterapia®


The first edition of the Annual Conference for Physiotherapy Professional (Constitution Club of India – Delhi) organised by the Indian Association of Physiotherapists has been chosen in order to formally launch Hilterapia® in India. “A prestigious occasion for our therapeutic solution – explains Giacomo Granozio, the ASAlaser Area Manager – which was the protagonist both of a speech given by Grammatiki Karagianni, a long-time user of Hilterapia®, and of the exhibition space reserved for the SH1 device by our local partner Biotech India”. Part of the scientific programme, the in-depth analysis of the ASAlaser Laser Therapy catalysed the attention of the more than 350 physiotherapists who attended and of prominent institutional figures, including Manoj Tiwari. The current member of the Indian Parliament mentioned the speech by Karagianni several times during the closing ceremony, showing his interest in the therapy in order to improve in-the-field activity.
An interest which was also shown by other industry professionals – concludes Granozio – for whom we held a targeted seminar at the All India Institute Of Medical Sciences, a first-class showcase not only for Delhi, but for the whole Country. Attendance was considerable, thereby confirming the interest of doctors and physiotherapists for Hilterapia®”. The course was structured over a theoretical session and a practical one, with the ASAlaser staff working jointly with Karagianni who, after presenting the biological and therapeutic effects of the therapy, used the SH1 device on various participants, affected by painful issues. “The seminar - concludes Granozio – included doctors who already used high-power lasers and who acknowledged the high educational level of our course, the immediate effectiveness of Hilterapia® on themselves and its total safety. Finally, participants showed their total understanding of our “global approach” concept and applied this with profound conviction both during the diagnosis and the application stages”.

< Back